| ¿µ¹® | chronic lymphocytic leukemia | ÇÑ±Û | ¸¸¼º¸²ÇÁ¼º ¹éÇ÷º´ |
|---|---|---|---|
| ¼³¸í | ¹éÇ÷º´(leukemia)¶õ ºñÁ¤»óÀûÀÎ ¹éÇ÷±¸ ¼¼Æ÷ÀÇ Áõ½Ä¿¡ ÀÇÇØ ÀϾ´Â º´ÀûÀÎ »óŸ¦ ¸»Çϴµ¥, ÈçÈ÷ ¸»ÃÊÇ÷¾×¿¡ ¹ÌºÐȼ¼Æ÷°¡ ³ªÅ¸³ª¸ç, Á¤»óÀûÀÎ ÀûÇ÷±¸¼¼Æ÷¿Í ¹éÇ÷±¸¼¼Æ÷, Ç÷¼ÒÆÇÀÇ ±Þ°ÝÇÑ °¨¼Ò¸¦ °¡Á®¿Í Á¤»óÀûÀÎ ¼¼Æ÷¿¡ ÀÇÇØ ÇàÇØÁö´Â ¿©·¯ ±â´ÉÀÇ °¨¼Ò¸¦ ÁÖÁõ»óÀ¸·Î ÇÏ¿© º´¿ø¿¡ ã¾Æ¿À°Ô µÈ´Ù. µû¶ó¼ ÀûÇ÷±¸¼¼Æ÷ÀÇ °¨¼Ò·Î ÀÎÇÑ ºóÇ÷, ¹éÇ÷±¸¼¼Æ÷ÀÇ °¨¼Ò·Î ÀÎÇÑ ¸¹Àº °¨¿°Áõ¼¼(ÈçÈ÷ °É¸®Áö ¾Ê´Â ¼¼±Õ¿¡ ÀÇÇÑ °¨¿°, Áö³ªÄ¡°Ô ÀæÀº °¨±â, Æó·Å µî), Ç÷¼ÒÆÇ¼¼Æ÷ÀÇ °¨¼Ò·Î ÀÎÇÑ ÃâÇ÷Áõ»óÀÌ ³ªÅ¸³´Ù. ¶ÇÇÑ ÇǸ¦ »ý»êÇÏ´Â °ñ¼ö Á¶Á÷¿¡¼´Â ÀÌ·± ºñÁ¤»óÀûÀÎ ¼¼Æ÷ÀÇ Áõ½Ä¸¸À» º¼ ¼ö ÀÖÀ¸¸ç, Á¤»óÀûÀÎ ¼¼Æ÷ÀÇ Áõ½ÄÀº º¸±â Èûµé´Ù. ¸¸¼º¸²ÇÁ¼º ¹éÇ÷º´Àº ¼¾ç¿¡¼´Â ºñ±³Àû ¹éÇ÷º´ Áß¿¡¼ ÈçÇÑ ÇüÀÌÁö¸¸ µ¿¾ç±Ç¿¡¼´Â ¾ÆÁÖ µå¹® ¹éÇ÷º´ÀÇ ÇüÅÂÀÌ´Ù. ´ë°³ 60¼¼ ÀÌ»óÀÇ °í·ÉÃþ¿¡¼ ¸¹ÀÌ »ý±â°í 30¼¼ ÀÌÇÏ¿¡¼´Â °ÅÀÇ Ã£¾Æº¼ ¼ö°¡ ¾ø´Ù. Ç÷¾×°Ë»ç»ó¿¡¼ ¸²ÇÁ±¸ÀÇ ¸¹Àº Áõ°¡¸¦ º¼ ¼ö°¡ ÀÖ°í, ´ë½Å¿¡ ´Ù¸¥ Ç÷¾×¼¼Æ÷µéÀº °¨¼Ò¸¦ ³ªÅ¸³½´Ù. ¹éÇ÷º´ Áß ¿¹Èİ¡ ÁÁÀº ÆíÀÌ¸ç ´ë°³ Ä¡·á´Â Ç×¾ÏÁ¦¸¦ ÀÌ¿ëÇÑ ÈÇпä¹ýÀ» ¸¹ÀÌ »ç¿ëÇϸç, Æò±Õ »ýÁ¸±â°£Àº 4~5³âÀÌ´Ù. |
||
| ¿µ¹® | lymphoma | ÇÑ±Û | ¸²ÇÁÁ¾ |
|---|---|---|---|
| ¼³¸í | ¸²ÇÁÀý¿¡ »ý±ä ¾Ç¼º Á¾¾ç. ÀÌ ¾ÏÀº ¹éÇ÷º´°ú´Â ´Ù¸£´Ù. ¸²ÇÁ¼º ¹éÇ÷º´Àº °ñ¼ö¿¡¼ »ý±ä ¸²ÇÁ±¸¼º ¾Ç¼ºÁ¾¾çÀÌÁö¸¸, ¸²ÇÁÁ¾Àº ¸²ÇÁÀý¿¡¼ »ý±ä ¸²ÇÁ±¸¼º ¾Ç¼ºÁ¾¾çÀÌ´Ù. ¸²ÇÁÁ¾Àº Å©°Ô 2°¡Áö Áï È£ÁöŲ¸²ÇÁÁ¾(Hodgkin's lymphoma)°ú ºñÈ£ÁöŲ¸²ÇÁÁ¾(Non-Hodgkin's lymphoma)À¸·Î ³ª´¼ö ÀÖ´Ù. ¶ÇÇÑ ºñÈ£ÁîŲ¸²ÇÁÁ¾Àº ¿©·¯ °¡ÁöÀÇ ¼¼Æ÷ÇüÅ¿¡ µû¶ó ³ª´©°í ÀÖ´Ù. ÀÌ º´Àº ´ÜÁö ¸²ÇÁÀý»Ó¸¸ ¾Æ´Ï¶ó Áö¶ó, °ñ¼ö, ÀÌ¿Ü ´Ù¸¥ ±â°üÀ» ħ¹üÇÔÀ¸·Î½á ¾Ç¼ºÀ̸ç, »ý¸í¿¡ Å« À§ÇùÀ» ÁØ´Ù. ƯÀÌÇÑ ÇüÅ·Π¹öŶ¸²ÇÁÁ¾(Burkitt's lymphoma)°¡ ÀÖ´Ù. ÀÌ º´Àº ÁÖ·Î ¾î¸°ÀÌ¿¡°Ô ÀϾ¸ç ÁÖ·Î Áß¾Ó ¾ÆÇÁ¸®Ä«¿¡ ¸¹ÀÌ ¹ß»ýÇÑ´Ù. ¶ÇÇÑ ÀÌ º´Àº ¹ÙÀÌ·¯½º(Ebstein Barr virus)¿¡ ÀÇÇØ¼ ÀϾ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ÁÖµÈ Ä§¹üºÎÀ§´Â ¾ó±¼ÀÇ ¾Æ·¡ÅλÀÀÌ´Ù. |
||
| ¿µ¹® | non-Hodgkin lymphoma | ÇÑ±Û | ºñÈ£ÁöŲ ¸²ÇÁÁ¾ |
|---|---|---|---|
| ¼³¸í | ¸²ÇÁÁ¾Àº ¸²ÇÁÀý¿¡ »ý±ä ¾Ç¼º Á¾¾çÀ¸·Î ¹éÇ÷º´°ú´Â ´Ù¸£´Ù. ¹éÇ÷º´Àº °ñ¼ö¿¡¼ »ý±ä ¸²ÇÁ±¸¼º ¾Ç¼ºÁ¾¾çÀÌÁö¸¸, ¸²ÇÁÁ¾Àº ¸²ÇÁÁ¶Á÷¿¡¼ »ý±ä ¸²ÇÁ±¸¼º ¾Ç¼ºÁ¾¾çÀÌ´Ù. Å©°Ô ¸²ÇÁÁ¾Àº 2°¡Áö·Î ³ª´ ¼ö ÀÖ´Â µ¥, È£ÁöŲº´(Hodgkin's lymphoma)°ú ºñÈ£ÁöŲ¸²ÇÁÁ¾(non-Hodgkin's lymphoma)À¸·Î ³ª´ ¼ö ÀÖ´Ù. ¶ÇÇÑ ºñÈ£ÁöŲ¸²ÇÁÁ¾Àº ¿©·¯ °¡ÁöÀÇ ¼¼Æ÷ÇüÅ¿¡ µû¶ó ³ª´©°í ÀÖ´Ù. ÀÌ º´Àº ´ÜÁö ¸²ÇÁÀý»Ó¸¸ ¾Æ´Ï¶ó Áö¶ó, °ñ¼ö, ÀÌ¿Ü ´Ù¸¥ ±â°üÀ» ħ¹üÇÔÀ¸·Î½á ¾Ç¼ºÀ̸ç, »ý¸í¿¡ Å« À§ÇùÀ» ÁØ´Ù. ¾Ç¼º¸²ÇÁÁ¾ÀÇ ÀÏÁ¾. ÀüÀÌÀÇ ÇüŰ¡ ´Ù¾çÇÏ¿©, ÁÖÀ§ ¸²ÇÁÀýÀ» °Ç³Ê¶Ù¾î ´Ù¸¥ ¸²ÇÁÀý·Î ÀüÀÌÇϱ⵵ ÇÑ´Ù. ¶ÇÇÑ ¼¼Æ÷ÀÇ ÇüÅ¿¡ µû¶ó ¿©·¯ °¡Áö Á¾·ù°¡ ÀÖÀ¸¸ç ´ë°³ Ä¡·á´Â ¹æ»ç¼±Ä¡·á¿Í ÈÇпä¹ýÀ» º¹ÇÕÇÏ¿© »ç¿ëÇÑ´Ù. |
||
| ¿µ¹® | small intestine | ÇÑ±Û | ÀÛÀºÃ¢ÀÚ, ¼ÒÀå |
|---|---|---|---|
| ¼³¸í | À§¿Í ūâÀÚ »çÀÌÀÇ ±æÀÌ 5m³»¿ÜÀÇ ¼Òȱâ°üÀ¸·Î¼ »ùâÀÚ, ºóâÀÚ, µ¹Ã¢ÀÚÀÇ ¼¼ ºÎºÐÀ¸·Î ±¸¼ºµÊ. 1)»ùâÀÚ: ¼ÒÀåÀÇ Á¦ÀÏ Ã¹ºÎºÐÀ¸·Î¼ ±æÀÌ 25cmÀÇ CÀÚÇü¸ð¾ç. »óºÎ, ³»¸², °¡·Î, ¿À¸§ÀÇ ³×ºÎÀ§·Î ±¸¼ºµÇ¸ç, »óºÎ ºÎÀ§¸¦ Á¦¿ÜÇϰí´Â ¸ðµÎ µÚº¹º®¿¡ °íÁ¤µÇ¾î ÀÖÀ¸¸ç ³»ºÎ¿¡´Â µ¹¸²ÁÖ¸§À̶ó´Â Á¡¸· ÁÖ¸§ÀÌ Á¸ÀçÇÔ. À§¿¡¼ ³Ñ¾î¿Â ¼ÒÈµÈ À½½ÄÀÌ ´ãÁó, ÀÌÀھ׿¡¼ ºÐºñµÇ´Â ¼ÒÈÈ¿¼Ò¾×)°ú ¼¯ÀÌ´Â Àå¼ÒÀ̸ç öÀÌ Èí¼öµÇ´Â Àå¼ÒÀÓ. 2)ºóâÀÚ:ÀÛÀºÃ¢ÀÚÀÇ µÎ¹øÂ° ºÎºÐÀ¸·Î¼ ±ÙÀ§ºÎ 2/5¸¦ Â÷ÁöÇÔ. °øÀåÀº ȸÀå¿¡ ºñÇØ Á÷°æÀÌ Å©°í À庮ÀÌ µÎ²¨¿ì¸ç Ç÷°üÀÌ Ç³ºÎÇϰí Àå°£¸·ÀÌ Åõ¸íÇϰí Á÷ÇàÇ÷°üÀÌ ±ä °ÍÀÌ Æ¯Â¡ÀÓ. 3)µ¹Ã¢ÀÚ:ÀÛÀºÃ¢ÀÚÀÇ ¸¶Áö¸· ºÎºÐÀ¸·Î¼ ¿øÀ§ºÎ 3/5À» Â÷ÁöÇÔ. ƯÈ÷ µ¹Ã¢ÀÚ, ūâÀÚ ÀÌÇàºÎ ºÎÀ§¿¡´Â ÆÄÀ̾îÆÇÀ̶ó´Â ¸²ÇÁÀýÀÌ Á¸ÀçÇϸç, À̰÷Àº °¢Á¾ Áúº´ÀÇ Áß¿äÇÑ ¹ß»ý ºÎÀ§°¡ µÊ. ´ãÁó¿° ¹× ºñŸ¹Î B12°¡ Èí¼öµÇ´Â Àå¼ÒÀÓ. |
||
| ¿µ¹® | small bowel series | ÇÑ±Û | ÀÛÀºÃ¢ÀÚ Á¶¿µ¼ú, ¼ÒÀå Á¶¿µ¼ú |
|---|---|---|---|
| ¼³¸í | ¹æ»ç¼± Á¶¿µÁ¦(¹æ»ç¼±°Ë»ç¿¡¼ ´Ù¸¥ ºÎÀ§¿Í ´ëÁ¶µÇ´Â ¾ÆÁÖ Èò»öÀ» ¶ì´Â ¹°Áú)ÀÎ ¹Ù·ýÀ» ¼·ÃëÇÑ µÚ, ÃÔ¿µÇÏ´Â ÀÛÀºÃ¢ÀÚÀÇ ±âº»ÀûÀÎ ¹æ»ç¼± °Ë»ç·Î¼, ¹æ¹ýÀº 200~300mLÀÇ ¹Ù·ýÀ» ¸ÔÀºµÚ ¹Ù·ýÀÌ ÀÛÀº âÀÚ¸¦ Åë°úÇÏ´Â µ¿¾È Á¤±ÔÀû °£°ÝÀ¸·Î ¹æ»ç¼± »çÁøÀ» ÂïÀ½. ÀϹÝÀûÀ¸·Î 2~3½Ã°£ÀÌ °É¸². |
||
| SLL | small lymphocytic lymphoma |
|---|---|
| ECG | Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ = EKG 1. Conducting System Structu... |
| DPDL | diffuse poorly differentiated lymphocytic lymphoma |
| DWDL | diffuse well-differentiated lymphocytic lymphoma |
| IDL | Index to Dental Literature; interface definition language; intermediate density lipoprotein; interme... |
| SLL | Small lymphocytic lymphoma |
|---|---|
| ILL | intermediate lymphocytic lymphoma |
| SNCL | Small non-cleaved-cell lymphoma |
| SNCCL | Small noncleaved cell lymphoma |
| ALL | Acute Lymphocytic Leukaemia |
| small lymphocytic lymphoma | <tumour> Essentially the same disease as chronic lymphocytic leukaemia, except that lymphocytes are not increased in the peripheral blood; lymph nodes are enlarged and other lymphoid tissue or bone marrow is infiltrated by small lymphocytes. Synonym: small lymphocytic lymphoma. (05 Mar 2000) |
|---|---|
| lymphoma, small lymphocytic | A low-grade malignant lymphoma that may, in some cases, be considered histologically identical to chronic lymphocytic leukaemia (cll; leukaemia, lymphocytic, chronic). It is diffuse in pattern, representing the neoplastic proliferation of well-differentiated B-lymphocytes. In patients with immunoglobulin gammopathies, the lymphocytes may exhibit plasmacytoid characteristics. (12 Dec 1998) |
| well-differentiated lymphocytic lymphoma | <tumour> Essentially the same disease as chronic lymphocytic leukaemia, except that lymphocytes are not increased in the peripheral blood; lymph nodes are enlarged and other lymphoid tissue or bone marrow is infiltrated by small lymphocytes. Synonym: small lymphocytic lymphoma. (05 Mar 2000) |
| poorly differentiated lymphocytic lymphoma | <tumour> A B-cell lymphoma with nodular or diffuse lymph node or bone marrow involvement by large lymphoid cells. Synonym: follicular predominantly small cleaved cell lymphoma, nodular histiocytic lymphoma. (05 Mar 2000) |
| lymphocytic lymphoma | <oncology, tumour> A cancer of lymphatic tissues, the tumour cells are mostly abnormal lymphocytes. (13 Nov 1997) |
| small bowel lymphoma | <radiology> Patterns:, infiltrative dilatation, nodular multiple filling defects, polypoid may cause intussiception from leading point associated with Burkitt lymphoma, endoexoenteric fistulae (12 Dec 1998) |
| diffuse small cleaved cell lymphoma | <tumour> A diffuse poorly differentiated lymphocytic lymphoma; follicular centre cell lymphoma that lacks a follicular pattern; malignancy is of intermediate grade. (05 Mar 2000) |
| follicular predominantly small cleaved cell lymphoma | <tumour> A B-cell lymphoma with nodular or diffuse lymph node or bone marrow involvement by large lymphoid cells. Synonym: follicular predominantly small cleaved cell lymphoma, nodular histiocytic lymphoma. (05 Mar 2000) |
| lymphoma, small-cell | A B-cell lymphoma presumably representing a tumour of interfollicular B-lymphocytes that may be functional. Those that are secrete identical immunoglobulin molecules. (12 Dec 1998) |
| lymphoma, small cleaved-cell, diffuse | An intermediate-grade malignant lymphoma in which the neoplastic cells (B-lymphocytes) exhibit variability in size, configuration, and degree of differentiation. The cells have distinctive nuclei, irregular in shape, with marked indentations and angularity. (12 Dec 1998) |
| lymphoma, small cleaved-cell, follicular | A low-grade malignant lymphoma of predominantly follicular pattern. Follicles are of relatively uniform size and shape and the cells are usually somewhat larger than normal lymphocytes. Nuclei are irregular with prominent indentations and cytoplasm can rarely be identified. Cells exhibiting these characteristics are often called centrocytes. (12 Dec 1998) |
| lymphoma, small noncleaved-cell | A high-grade malignant lymphoma that includes both burkitt tumour (burkitt lymphoma) and other lymphomas previously designated undifferentiated non-burkitt type. Nuclei in burkitt tumour are round to ovoid and uniform in size. The non-burkitt type exhibits greater nuclear variation and less evidence of cellular maturation with a correspondingly lesser degree of differentiation. (12 Dec 1998) |
| acute lymphocytic leukaemia | <radiology> 95% of cases of leukaemia in children, bone changes in 50-70% of kids (vs. 10% in adults); seen as early as 1 month after onset of symptoms, wrists and knees most commonly affected, bony defects: metaphyseal radiolucent bands! (similar findings in scurvy, JRA, syphilis), osteolytic lesions, periosteal reaction, osteosclerosis (12 Dec 1998) |
| acute non-lymphocytic leukaemia | <haematology> A form of leukaemia which is characterised by the proliferation of immature bone marrow precursor cells in the marrow and immature white blood cells (granulocytes) in the bloodstream. Occurs primarily in adults and in infants under 1 year of age. Complications include abnormal bleeding and susceptibility to infections. Symptoms include fatigue, weight loss, fevers, weakness, pallor, bone pains, bleeding gums, nosebleeds, easy bruising, enlarged lymph nodes and joint pains. Trisomy-8 is the most common cytogenetic abnormality observed, followed by monosomy-7 and monosomy-5. Approximately 8% of cases show trisomy-8, mostly in AML (M1), AM (M4) and acute monocytic leukaemia (M5). Many pre-leukaemic conditions, acute non-lymphocytic leukaemia and secondary leukemia show monosomy-7 or deletion of the long arm of chromosome 7. Treatment includes chemotherapy and/or bone marrow transplant. Acronym: ANLL Incidence: 2.5 cases per 100,000 (all ages). Origin: Gr. Haima = blood (07 Apr 1998) |
| chronic lymphocytic leukaemia | <haematology> A slowly progressing form of leukaemia, characterised by an increased number of the type of white blood cell known as lymphocytes. With about 3, 500 new cases occurring each year in the UK, it is the most common form of leukaemia and occurs predominantly in late middle age onwards. It has variable symptoms and course, but may be diagnosed by chance before the patient develops any clinical symptoms of disease. Acronym: CLL Origin: Gr. Haima = blood (12 Jan 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|